Qing Zhou Selected Research

Hypotension (Low Blood Pressure)

1/2021	Predictive Factors for In-Hospital Preoperative Rupture in Hyperacute Type A Aortic Dissection.
1/2018	A prediction score for significant coronary artery disease in Chinese patients ≥50 years old referred for rheumatic valvular heart disease surgery.
11/2009	Effects of propofol on pro-inflammatory cytokines and nuclear factor kappaB during polymicrobial sepsis in rats.
9/2009	[The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock].
10/2008	The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats.
12/2006	Effects of ketamine on proinflammatory cytokines and nuclear factor kappaB in polymicrobial sepsis rats.
1/2005	[Protective effect of the cholinergic anti-inflammatory pathway against hemorrhagic shock in rats].
6/2004	[Protective effect of ketamine against septic shock in rats].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing Zhou Research Topics

Disease

164	Neoplasms (Cancer) 11/2022 - 12/2005
79	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 10/2006
36	Inflammation (Inflammations) 04/2022 - 02/2009
33	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2005
23	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2007
18	Aortic Dissection 01/2022 - 08/2013
16	Infections 06/2022 - 06/2002
16	Adenocarcinoma of Lung 01/2022 - 07/2007
15	Atherosclerosis 04/2022 - 08/2003
15	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2008
14	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2009
14	Atrial Fibrillation 11/2021 - 07/2013
13	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 06/2002
13	Myocardial Infarction 06/2022 - 11/2009
11	Fibrosis (Cirrhosis) 10/2022 - 03/2009
11	Hypoxia (Hypoxemia) 02/2022 - 01/2012
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2009
10	Wounds and Injuries (Trauma) 01/2022 - 01/2013
9	Glioma (Gliomas) 02/2022 - 10/2002
9	Disease Progression 01/2022 - 02/2007
9	Hypertension (High Blood Pressure) 01/2022 - 07/2010
9	Urinary Bladder Neoplasms (Bladder Cancer) 07/2021 - 12/2015
9	Carcinoma (Carcinomatosis) 01/2021 - 10/2004
8	Carcinogenesis 10/2022 - 06/2002
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022 - 01/2015
8	Liver Neoplasms (Liver Cancer) 02/2022 - 01/2016
8	Hypotension (Low Blood Pressure) 01/2021 - 06/2004
8	Adenocarcinoma 11/2019 - 02/2007
7	Infarction (Infarctions) 06/2022 - 04/2014
7	Hyperglycemia 01/2022 - 01/2014
7	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2013
7	Hemorrhage 01/2022 - 01/2005
7	Fever (Fevers) 01/2021 - 03/2011
7	Heart Failure 01/2021 - 03/2009
7	Septic Shock (Toxic Shock Syndrome) 01/2021 - 06/2004
7	Stomach Neoplasms (Stomach Cancer) 01/2019 - 03/2012
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2022 - 01/2021
5	Chronic Obstructive Pulmonary Disease (COPD) 06/2022 - 01/2020
5	Mitochondrial Diseases (Mitochondrial Disease) 02/2022 - 01/2019
5	Insulin Resistance 01/2022 - 01/2016
5	Osteoarthritis 01/2022 - 04/2020
5	Paraplegia (Spastic Paraplegia) 01/2022 - 10/2004

Drug/Important Bio-Agent (IBA)

50	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2005
38	ErbB Receptors (EGF Receptor)IBA 11/2022 - 05/2007
34	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2008
30	Tyrosine Kinase InhibitorsIBA 11/2022 - 05/2010
19	Pharmaceutical PreparationsIBA 01/2022 - 02/2007
18	Gefitinib (Iressa)FDA Link 11/2022 - 10/2006
18	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2009
16	Messenger RNA (mRNA)IBA 02/2022 - 06/2006
13	RNA (Ribonucleic Acid)IBA 10/2022 - 12/2005
13	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 10/2004
12	Small Interfering RNA (siRNA)IBA 10/2022 - 12/2011
12	Myosin-Light-Chain KinaseIBA 11/2020 - 06/2013
12	CytokinesIBA 01/2020 - 06/2004
11	Immune Checkpoint InhibitorsIBA 11/2022 - 12/2018
11	Biological ProductsIBA 04/2022 - 12/2011
11	Long Noncoding RNAIBA 11/2021 - 12/2015
11	MelatoninIBA 01/2019 - 10/2008
10	EnzymesIBA 10/2022 - 03/2012
10	LigandsIBA 01/2022 - 09/2013
10	LipidsIBA 01/2022 - 11/2008
9	Cell-Free Nucleic AcidsIBA 10/2022 - 01/2016
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 02/2009
9	CholesterolIBA 01/2022 - 08/2003
9	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2014
9	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2020 - 01/2005
8	B7-H1 AntigenIBA 01/2022 - 11/2018
8	Transcription Factors (Transcription Factor)IBA 05/2021 - 06/2009
8	Bevacizumab (Avastin)FDA Link 01/2021 - 06/2012
8	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2018 - 01/2011
7	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2005
7	Oxygen (Dioxygen)IBA 10/2020 - 10/2007
6	Interleukin-6 (Interleukin 6)IBA 06/2022 - 06/2004
6	CollagenIBA 02/2022 - 07/2013
6	Circular RNAIBA 01/2022 - 01/2019
6	oxidized low density lipoproteinIBA 01/2022 - 10/2008
6	AntigensIBA 01/2021 - 12/2005
6	PlatinumIBA 10/2020 - 02/2007
6	Anaplastic Lymphoma KinaseIBA 01/2020 - 07/2010
6	NF-kappa B (NF-kB)IBA 01/2019 - 01/2005
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 06/2004
5	Liposomes (Liposome)IBA 10/2022 - 01/2021
5	Matrix Metalloproteinases (MMPs)IBA 02/2022 - 03/2009
5	AcidsIBA 01/2022 - 06/2013
5	Hormones (Hormone)IBA 01/2022 - 03/2012
5	osimertinibIBA 01/2022 - 01/2018
5	Adenosine DeaminaseIBA 01/2022 - 03/2014

Therapy/Procedure

71	Therapeutics 10/2022 - 05/2007
34	Drug Therapy (Chemotherapy) 11/2022 - 10/2006
25	Immunotherapy 01/2022 - 12/2005
11	Stents 07/2021 - 04/2009
10	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2002
8	Microbubbles 06/2022 - 08/2015
7	Thoracotomy 10/2020 - 04/2009
6	Precision Medicine 11/2021 - 10/2010
6	Transplantation 01/2021 - 10/2004
6	Catheter Ablation 01/2019 - 01/2014
5	Aftercare (After-Treatment) 06/2022 - 01/2015
5	Radiotherapy 01/2022 - 01/2012